Geode Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-910,419
| Closed | -$47.8M | – | 4359 |
|
|
2020
Q3 | $47.8M | Sell |
910,419
-916,074
| -50% | -$37.9M | 0.01% | 940 |
|
|
2020
Q2 | $60.8M | Buy |
1,826,493
+85,981
| +5% | +$2.74M | 0.01% | 792 |
|
|
2020
Q1 | $47.3M | Buy |
1,740,512
+242,241
| +16% | +$6.74M | 0.01% | 796 |
|
|
2019
Q4 | $29.6M | Buy |
1,498,271
+161,650
| +12% | +$2.58M | 0.01% | 1294 |
|
|
2019
Q3 | $17.3M | Buy |
1,336,621
+47,392
| +4% | +$572K | ﹤0.01% | 1578 |
|
|
2019
Q2 | $16.1M | Buy |
1,289,229
+77,035
| +6% | +$1.02M | ﹤0.01% | 1637 |
|
|
2019
Q1 | $17.6M | Buy |
1,212,194
+153,080
| +14% | +$1.96M | ﹤0.01% | 1502 |
|
|
2018
Q4 | $11.7M | Buy |
1,059,114
+223,085
| +27% | +$3.1M | ﹤0.01% | 1683 |
|
|
2018
Q3 | $22M | Buy |
836,029
+37,146
| +5% | +$1M | 0.01% | 1344 |
|
|
2018
Q2 | $16.3M | Buy |
798,883
+71,208
| +10% | +$1.53M | 0.01% | 1509 |
|
|
2018
Q1 | $13.2M | Sell |
727,675
-10,832
| -1% | -$181K | ﹤0.01% | 1564 |
|
|
2017
Q4 | $10.3M | Sell |
738,507
-1,815
| -0.2% | -$24.5K | ﹤0.01% | 1720 |
|
|
2017
Q3 | $13.7M | Buy |
740,322
+120,166
| +19% | +$2.01M | 0.01% | 1508 |
|
|
2017
Q2 | $10.5M | Buy |
620,156
+91,279
| +17% | +$1.39M | ﹤0.01% | 1628 |
|
|
2017
Q1 | $7.06M | Buy |
528,877
+50,289
| +11% | +$788K | ﹤0.01% | 1870 |
|
|
2016
Q4 | $7.2M | Buy |
478,588
+14,557
| +3% | +$192K | ﹤0.01% | 1816 |
|
|
2016
Q3 | $5.42M | Buy |
464,031
+26,894
| +6% | +$316K | ﹤0.01% | 1919 |
|
|
2016
Q2 | $4.72M | Buy |
437,137
+11,626
| +3% | +$120K | ﹤0.01% | 1955 |
|
|
2016
Q1 | $3.93K | Buy |
425,511
+26,893
| +7% | +$289K | ﹤0.01% | 2026 |
|
|
2015
Q4 | $5.91M | Buy |
398,618
+2,980
| +0.8% | +$49.9K | ﹤0.01% | 1752 |
|
|
2015
Q3 | $6.49M | Buy |
395,638
+12,244
| +3% | +$251K | ﹤0.01% | 1667 |
|
|
2015
Q2 | $8.74M | Buy |
383,394
+96,031
| +33% | +$1.91M | 0.01% | 1503 |
|
|
2015
Q1 | $4.37M | Buy |
287,363
+11,202
| +4% | +$146K | ﹤0.01% | 1937 |
|
|
2014
Q4 | $3.32M | Sell |
276,161
-3,698
| -1% | -$42.3K | ﹤0.01% | 2077 |
|
|
2014
Q3 | $3.17M | Sell |
279,859
-20,155
| -7% | -$230K | ﹤0.01% | 2067 |
|
|
2014
Q2 | $3.62M | Buy |
300,014
+65,329
| +28% | +$772K | ﹤0.01% | 1990 |
|
|
2014
Q1 | $2.73M | Buy |
234,685
+9,416
| +4% | +$159K | ﹤0.01% | 2156 |
|
|
2013
Q4 | $3.98M | Buy |
225,269
+6,911
| +3% | +$116K | ﹤0.01% | 1866 |
|
|
2013
Q3 | $3.14M | Buy |
218,358
+29,763
| +16% | +$456K | ﹤0.01% | 1901 |
|
|
2013
Q2 | $2.84M | Buy |
+188,595
| New | +$2.49M | ﹤0.01% | 1815 |
|
Geode Capital Management's MNTA Position: Q4 2020 in Review
Geode Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 910,419 shares — an estimated $47.8M sold.
Geode Capital Management first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $60.8M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Geode Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Geode Capital Management sold 910,419 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $47.8M.
- Geode Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Geode Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $60.8M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.